Thu, Apr 17, 2014, 5:40 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Momenta Pharmaceuticals Inc. Message Board

  • thegunnerab thegunnerab Nov 2, 2011 1:18 PM Flag

    Watson's Appeal

    From Watson's earnings calls transcript:

    I think MNTA is safe for a year or more...

    The Gunner

    -------------------------------------------------
    Gregory B. Gilbert - BofA Merrill Lynch, Research Division

    My first one is on LOVENOX, Paul. I know it's excluded from guidance, but can you walk us through the possible timeline and outcomes, and of course, your personal view on what's likely to happen? And then I have a second.

    Paul M. Bisaro

    Sure. I think, as you probably know, an appeal has been filed. I think that process is going to take some time even if we get an expedited review or an expedited treatment of that appeal. I think we -- as from what we can see, I think we believe we're going to -- we have a strong case on appeal, and we'll take it from there. What I -- timeline here is really going to be dependent on what the Federal Circuit is -- how quickly they're going to move on this. So I think we still stand ready to launch the product as soon as possible, and we'll wait and see. But at the moment, as you said, we have excluded it from guidance for the rest of 2011.

    Gregory B. Gilbert - BofA Merrill Lynch, Research Division

    Just to frame the book ends, would you say it's a couple of months fastest case and maybe a couple of years longer case? Is that reasonable? Or could it be faster?

    Paul M. Bisaro

    I think it's probably fast as to probably 3 months, and longest case could be a year.

 
MNTA
11.10-0.46(-3.98%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.